Fidelity BioPharma Co.

FDA Regulatory Profile

Fidelity BioPharma Co. appears in FDA public data with 0 recalls, 1 510(k) clearance, 0 FDA inspections, and 0 compliance actions on record. Its most recent 510(k) clearance was granted on September 6, 2026.

Summary

Total Recalls
0
510(k) Clearances
1
Inspections
0
Compliance Actions
0

Recent 510(k) Clearances

K-NumberDeviceDate
K260396KCS rTMS Therapy System (Transcranial Magnetic Stimulator) (MetaStim 100, MetaStim 100A)September 6, 2026